Conjugated linoleic acids (CLA) have been shown to decrease body fat content in pigs. It is possible that feeding pigs diets rich in CLA may increase carcass lipid CLA to levels that could provide health benefits when included as a part of a healthy diet. Therefore, the aim of the present study was to determine whether dietary CLA supplementation has any effect on the fatty acid composition of subcutaneous and intramuscular adipose tissue in pigs. Thirty-five female cross bred (Large White £ Landrace) pigs (initial weight 57·2 kg and initial P2 back fat 11·5 mm) were used in the present study. Pigs were housed individually and randomly allocated to one of six dietary treatments (0·00, 1·25, 2·50, 5·00, 7·50 and 10·00 g CLA55 (55 g CLA isomers/100 g total fatty acids; Natural Lipids Ltd, Hovdebygda, Norway)/kg) and fed their respective diets for 8 weeks. Twelve CLA isomers in the diet and in pig tissue lipids were separated by Ag þ -HPLC. CLA was incorporated at fivefold higher levels in subcutaneous fat as compared with intramuscular fat and in a dose-dependant manner. Overall, the transfer efficiency of CLA was maximized at 5·00 g CLA55/kg. However, there was clear selectivity in the uptake or incorporation of cis,trans-9,11 isomer over the trans,cis-10,12 isomer. In general, CLA supplementation produced significant changes in skeletal muscle and adipose tissue fatty acid composition, indicating that dietary CLA had a potent affect on lipid transport and metabolism in vivo. Significant increases in myristic, palmitic and palmitoleic acids and a reduction in arachidonic acid were observed, suggesting an alteration in activity of D 5 -, D 6 -and D 9 -desaturases in pig adipose tissue. In conclusion, feeding pigs diets supplemented with CLA increases carcass lipid CLA, but also results in changes in the fatty acid profile in pig fat that could potentially outweigh the benefits of CLA.
With the increasing awareness of the importance of healthy diet in cancer prevention, there is interest in the manipulation of animal products to meet consumer demands for functional foods (Jiménez-Colmenero, 2001) . There is convincing evidence from rodent models and in vitro models of carcinogenesis indicating that conjugated linoleic acid (CLA) is a potent naturally occurring anti-carcinogen (Shultz et al. 1992; Ip et al. 1994; Parodi, 1994; Durgam & Fernandes, 1997) . Human clinical and epidemiological results are more equivocal, with one study showing an inverse association between dietary and serum CLA and risk of breast cancer, particularly in postmenopausal women (Aro et al. 2000) , although this was not confirmed in another study (Voorrips et al. 2002) . CLA is a mixture of positional and geometric isomers (18 : 2n-6) of linoleic acid (cis-9,cis-12-octadecadienoic acid) with conjugated double bonds at positions 9,11-, 10,12-or 11,13-on the C-chain of linoleic acid. The most common form in human diets is cis-9, trans-11 CLA and the major source is the consumption of fat in dairy products (Ritzenthaler et al. 2001) . Based on animal results, it was estimated that consumption of a diet containing as little as 1 g CLA/kg dry diet is sufficient to significantly reduce the incidence of tumours (Ip et al. 1994) . Unfortunately, with the increasing consumption of low-fat dairy products and consequently a reduced intake of dairy fat, the richest source of CLA, these levels are often not met. Therefore, development of CLA-fortified products may help to increase the intake of CLA in the human diet; clearly more clinical studies are required before recommendations on the optimum amount of CLA in the human diet can be made.
Meanwhile, the potential to increase the level of CLA in animal fats via CLA supplementation of animal diets is being explored. Consumption of CLA-enriched animal products by human subjects could help to increase the CLA intake, since animal fat constitutes about 60 % of the fat available for consumption in developed countries such as Australia (Anonymous, 2000) . Dietary CLA has been shown to be readily incorporated into liver and muscle lipids of the laboratory animals (Chin et al. 1994; Park et al. 1995; Banni et al. 1996; Belury & Kempa-Steczko, 1997) , but the incorporation of CLA varied according to the amount present in the diet and the length of time of intake (Banni et al. 1996; Ip et al. 1996; Belury & Kempa-Steczko, 1997) . CLA supplementation has also been reported as modifying fatty acid composition in pig tissue (O'Quinn et al. 2000; Eggert et al. 2001; Ramsay et al. 2001; Joo et al. 2002) . The current study is an extension of our previous report (Ostrowska et al. 2003) , where the supplementation of commercially sourced CLA (consisting of a mixture of at least twelve CLA isomers) was shown to improve performance and carcass composition. The objective of the present study was to investigate the effect of CLA supplementation on the fatty acid composition of adipose tissue and intramuscular fat of pork.
Experimental methods

Animals and sample collection
All procedures involving animals were approved by the Victorian Institute of Animal Science Animal Ethics Committee (Anonymous, 1997) . Thirty-five (Large White £ Landrace) pigs were used in the experiment. Five pigs were killed at the beginning of the experiment. The remaining thirty pigs were blocked according to the live weight (57·2 (SD 1·9) kg) and back-fat thickness (11·5 (SD 1·3) mm) and randomly allocated to one of six dietary treatments. The CLA used in the present study was prepared from sunflower oil and contained 55 g CLA isomers in non-esterified fatty acid form/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). The CLA concentrations for the six diets were 0·00, 1·25, 2·50, 5·00, 7·50 or 10·00 g CLA55/kg diet or 0·00, 0·70, 1·40, 2·75, 4·10 and 5·50 g total CLA/kg diet. The CLA content of the supplement and diets was measured by HPLC as described later Ostrowska et al. 2000) .
The experimental diets were formulated to contain 14·3 MJ digestible energy, 9·3 g lysine and 175 g crude protein (N £ 6·25)/kg air-dry diet, which was in excess of protein and lysine requirements for the class of pig used in the study (Dunshea et al. 1993) . The detailed diet composition has been published elsewhere (Ostrowska et al. 2003) . The amino acid content relative to lysine was kept in excess of the amino acid balance proposed as ideal by the Standing Committee on Agriculture (1987) to ensure that lysine was the first limiting amino acid. Diets were fed ad libitum for 8 weeks and unlimited access to water was provided via nipple drinkers. Pigs were housed individually to allow measurement of individual feed intake daily and live weight measurements weekly.
After 8 weeks, pigs were slaughtered at an average live weight of approximately 107 kg (Ostrowska et al. 2003) . Two samples of adipose tissue were collected from the P2 site (65 mm from the midline over the last rib): the inner layer (adjacent to longisimus thoracis muscle) of fat and the outer layer of fat (5 mm beneath the skin) were collected immediately after slaughter. Samples of muscle tissue were also collected from longissimus thoracis at the P2 site. The samples were stored at 2 808C before being analysed for the fatty acid composition and CLA isomer profile.
Sample preparation for fatty acid analysis
Fat was extracted using a chloroform-methanol (2:1, v/v) method (Folch et al. 1957) . Preparation of non-esterified CLA was carried out according to the procedure of Ha et al. (1989) . For GC analysis, non-esterified fatty acids were derivatized into methyl esters using the BF 3 method (Association of Official Analytical Chemists, 1995).
CLA were separated by HPLC using a ChromSpher 5 Lipids analytical (4·6 mm internal diameter £ 250 mm, stainless steel, 5 mm particle size) Ag-impregnated column (Chrompack, Bridgewater, NJ, USA). The column was protected by a 3·0 mm internal diameter £ 10 mm guard column containing the same stationary phase. HPLC analyses were performed with a Varian (Walnut Creek, CA, USA) isocratic solvent delivery system equipped with a 9012 pump, a Prostar 330 photodiode array detector (ProStar, Varian Inc, Palo Alto, CA, USA) and a Star Workstation (version 5.3 Star software; Varian Inc.). All absorbances were measured at 234 nm. Samples were introduced via a Rheodyne (Cotati, CA, USA) 8125 injector fitted with a 5 ml injection loop. A Timberline (Eureka, OR, USA) column heater maintained the temperature at 308C for all runs. Minimum tubing diameters and distances were used between the injector and detector. The conditions used for separation of CLA non-esterified fatty acids in pig tissue were glacial acetic acid (25 ml/l) and acetonitrile (0·25 ml/l) at a flow rate of 1 ml/min. GC analysis of fatty acid methyl esters was carried out with a 3400 Varian GC (Varian Inc.) fitted with a flame ionization detector. A HP-INNO Wax (Hewlett Packard, Palo Alto, CA, USA), polyethylene glycol fused silica capillary column (60 m £ 0·32 mm (internal diameter), 0·25 mm film thickness) was used with he as the carrier gas at a flow rate of 2 ml/min (81·36 kPa).
Lipid standard (Sigma-Aldrich Pty Ltd, Castle Hill, NSW, Australia) containing thirty-seven different fatty acid methyl esters was used to determine the best conditions for separating all fatty acids present. The lipid standard was then spiked with the 99 % pure CLA standard (Sigma-Aldrich Pty Ltd) containing twelve isomers, to ensure there was minimal overlapping of the peaks with the remaining fatty acid methyl esters. The conditions chosen were as follows: injector temperature set at 2508C, detector temperature at 2508C and oven temperature programmed into four progressive steps: step 1, 508C held for 1 min; step 2, 50 -1008C at 208C/min and held for 1 min; step 3, 100 -1808C at 208C/min and held for 2 min; step 3, 180-1958C at 18C/min and held for 1 min; step 4, 195 -2308C at 108C/min and held for 30 min. The volume injected ranged from 1·0 to 3·0 ml. The CLA fatty acids and other fatty acid methyl ester peaks were identified by comparison with the retention time of the reference standard.
Calculations and statistical analysis
Transfer efficiencies of the CLA isomers into porcine tissue were calculated using the following formula: transfer efficiency ð%Þ ¼ ððfin: CLA 2 init: CLAÞ 2 T 0 fin: CLA 2 T 0 init: CLAÞ £ =total CLA mass consumedÞ £ 100;
where fin. CLA is the final CLA mass (g), init. CLA is the initial CLA mass (g), T 0 fin. CLA is the final CLA mass (g) in the control group of pigs and T 0 init. CLA is the initial CLA mass (g) in the control group of pigs.
One assumption in the estimations of transfer efficiencies was that the initial intramuscular fat content was a uniform value of 1·5 % body weight. This was based on the analysis performed on the five pigs that were killed at the beginning of the experiment. The estimations of the initial fat and lean contents for the individual pigs were obtained by the dual -energy X -ray absorptiometry. The total intramuscular fat mass at the beginning of the experiment was calculated by multiplying the initial intramuscular % fat by dual -energy X -ray absorptiometry estimation of the total lean content for every pig (Ostrowska et al. 2003) . The initial subcutaneous fat content was assumed to be the difference between the estimation of initial fat content by dual -energy X -ray absorptiometry and the estimation of the initial intramuscular fat content. The subcutaneous CLA content at the beginning of the experiment was assumed to be a sum of CLA found in the inner and the outer layers of fat, and equal to the amount found in the control group of pigs at the end of the experiment, multiplied by the initial content of total subcutaneous fat. Similarly, the initial intramuscular CLA contents were assumed to be equal to the amount found in the control group at the end of the experiment.
Statistical analysis
Data were analysed by ANOVA suitable for a doseresponse, with linear and quadratic effects determined. The model included replicate and CLA dose. In addition, comparisons were made between diets containing either none or added CLA. For these analyses, the model included block, replicate and CLA dose. All analyses were performed using GENSTAT for Windows, version 4.1 (Payne et al. 1993) .
Results
Appropriate blocking ensured that there was no difference in live weight (57·2 kg, P¼ 0·76) or P 2 (11·5 mm, P¼ 0·20) back fat between the different dietary CLA groups at the commencement of the study. Effects of dietary CLA on growth performance have been presented elsewhere, but briefly, there was no effect of CLA on average daily gain, while there was a small improvement in the ratio feed:gain with dietary CLA supplementation (Ostrowska et al. 2003) . Significantly linear dose -dependent reductions in fat mass were observed in the carcass at the end of the study (Ostrowska et al. 2003) .
The isomer composition of the dietary CLA, which was analysed by Ag þ -HPLC, is shown in Table 1 . Once CLA was mixed in the diet, both GC and Ag þ -HPLC analyses were used to confirm the content of CLA. Table 2 shows the GC analysis of the fatty acid composition of the fats extracted from the diets. The chromatographic analysis of the fats extracted from the diets confirmed that the dietary CLA was present at the expected levels (0·00, 0·69, 1·38, 2·75, 4·13 and 5·50 g CLA/kg diet). However, the substitution of CLA with soyabean oil resulted in small differences in the fatty acid profile of the fats extracted from the diets ( Table 2) . For example, soyabean oil consisted of about 500 g linoleic acid (18 : 2)/kg with 450 g commercial mixture of CLA55/kg. Hence, control diets were slightly higher in linoleic acid content as compared with diets supplemented with CLA. This was also the case for myristic (14 : 0), palmitic (16 : 0), stearic (18 : 0) and linolenic acids (18 : 3), whereas the concentration of g-linoleic (g-18 : 3) acid increased with the dietary CLA in the diet.
Ag þ -HPLC analysis of the CLA isomer composition in the outer layer and inner layers of fat and intramuscular fat are presented in Tables 3, 4 and 5 respectively. Small amounts of CLA were detected in pigs fed the control diets, with the highest quantity present in the inner layer of fat (1·73 mg/g fat), followed by the outer layer (0·68 mg/g fat), and lowest in the intramuscular fat (0·43 mg/g fat). The concentration of CLA detected varied across different fat depots; however, in all cases the levels increased in a linear fashion with the increasing level of dietary CLA in the diet. The significant (P, 0·001) linear Table 1 . Distribution of non-esterified conjugated linoleic acid (CLA) isomers in the CLA fraction of the commercial preparation of CLA55* CLA isomer g/100 g total CLA isomers cis,trans/trans,cis-11,13 † 18·33 cis,trans/trans,cis-10,12 † 30·45 cis,trans/trans,cis-9,11 † 24·53 cis,trans/trans,cis-8,10 † 13·83 trans,trans-11,13 0·18 trans,trans-10,12 0·44 trans,trans-9,11 2·04 trans,trans-8,10
2·90 cis,cis-11,13 0·82 cis,cis-10,12 2·64 cis,cis-9,11 3·18 cis,cis-8,10 ND Total 99·35 ND, not detected. * CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). † The slash between geometric isomers (i.e. cis,trans/trans,cis) means that either or both of the two isomers could be present.
increase in the concentration was evident for all the individual isomers of CLA detected in pig tissues. In the inner layer of fat and at the highest level of CLA supplementation as much as 15·10 mg total CLA was detected per g total lipids (Table 4 ). Slightly less CLA was detected in the outer layer of fat (13·50 mg/g fat; Table 3 ) and fivefold lower concentrations were detected in the intramuscular fat (2·88 mg/g fat; Table 5 ). In terms of individual isomers of CLA, the cis,trans-9,11 isomer was most abundant in all three fat depots. At the highest level of dietary CLA supplementation, the levels were 5·51, 5·63 and 0·70 mg/g fat collected from outer layer, inner layer and intramuscular fats respectively (Tables 3, 4 and 5). In the trans,trans and cis,cis group of isomers, the 9,11 isomer was also most abundant in all three fat depots, followed by a 10,12 homolog (Tables 3, 4 and 5) . Approximately one-third (29·28 %) of the total dietary CLA consumed by the pigs was incorporated into carcass lipid (sum of intramuscular, the inner and the outer layers of fat; Table 6 ). The highest transfer efficiency value (39·17 %) was recorded for the group of pigs fed the intermediate level of dietary CLA (5·00 g/kg). The transfer efficiency of CLA into the intramuscular fat was maximized (0·76 %) at 7·50 g CLA/kg diet ( Table 6 ). The distribution of CLA isomers isolated from the intramuscular fat appears similar to that found in the diet; however, the incorporation of some isomers was less than that of others ( Table 6 ). The most evident difference was in the incorporation of the trans,cis-10,12 isomer, which was the most abundant isomer in the CLA mixture fed to the pigs, but the least efficiently incorporated isomer in the porcine tissue. For the individual isomers in the cis,trans region, the transfer efficiencies in the intramuscular fat were maximized at the dietary CLA level of 7·50 g/kg (1·18, 0·36, 0·94 and 1·03 % for cis,trans-11,13, -10,12, -9,11 and -8,10 isomers respectively).
The transfer efficiency of the dietary CLA was much greater (P, 0·001) in the subcutaneous fat, at 28·78 % across all dietary levels of CLA compared with 0·50 % in the intramuscular fat (Table 6 ). The incorporation of total CLA into adipose tissue was maximized at dietary CLA concentration of 5·00 g/kg (38·42 %) followed by 7·50 g CLA/kg (37·58 %). The incorporation efficiencies estimated for the individual isomers (Table 6) show that the trans,cis 2 10,12 isomer was the least abundant isomer found in the subcutaneous fat. Overall, 13·30 % of this isomer was incorporated into subcutaneous fat. The cis,trans 2 9,11 was the most efficiently incorporated isomer, with almost half (46·40 %) of the amount of this isomer fed to the pig being incorporated into the adipose tissue. The second most efficiently incorporated isomer was the trans,cis 2 8,10 (28·78 %), followed by the cis,trans 2 11,13 isomer (20·81 %). The transfer efficiency of the cis,trans 2 9,11 isomer was maximized at the dietary CLA level of 5·00 g/kg (66·4 %). The cis,trans 2 8,10 homolog was incorporated most efficiently at concentration of 7·50 g dietary CLA/kg diet (39·23 %). The transfer efficiencies for the remaining two isomers in the cis,trans group were maximized (29·72 and 18·16 % for cis,trans 2 11,13 and 2 10,12 respectively) at the highest level of supplementation.
The transfer efficiencies for total CLA and the individual isomers tended to increase significantly (P, 0·001) with the increasing dietary level of CLA. The lowest value of transfer efficiency was recorded at the dietary CLA concentration of 1·25 g/kg (7·40 %). This could be partially due to the assumptions made in regards to the levels of CLA found in the adipose tissue at the beginning of the experiment. Because the CLA isomer composition of pigs at the beginning of the experiment was not analysed, the value adopted in the calculations of the transfer efficiencies was the concentration found in the control group of pigs at the end of the experiment. The concentrations of CLA are anticipated to be higher in heavier pigs than younger pigs, since CLA is known to originate from dietary sources and its accumulation in tissue is time dependent. Hence, the transfer efficiencies are possibly slightly underestimated and the values calculated for the lowest level of dietary CLA tended to be most sensitive to this assumption; in some pigs, the transfer efficiency values resulted in negative values.
The GC results of the fatty acid profiles in adipose and muscle tissues are presented in Tables 7 and 8. The distribution of fatty acids was clearly affected by dietary 
ND, not detected. * Fats were extracted using chloroform -methanol (2:1, v/v) method (Folch et al. 1957) ; total fat extracted from the diets was 36 (SD 1·2) g/kg diet. † Diets 1 -6 correspond to different dietary levels of CLA included in the diet: (g CLA/kg diet): diet 1 (control) 0·00, diet 2 1·25, diet 3 2·50, diet 4 5·00, diet 5 7·50, diet 6 10·00. Table 3 . 
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,0·001 c, cis; t, trans. * For details of diets and procedures, see Tables 1 and 2 and p. 916. † CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). ‡ The slash (/) between geometric isomers (i.e. cis,trans/trans,cis) means that either or both of the isomers could be present. § SED between different doses of CLA55 (five per treatment group).
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0·15 0·002 0·011 ,0·001 c, cis; t, trans. * For details of diets and procedures, see Tables 1 and 2 and p. 916. † CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). ‡ The slash (/) between geometric isomers (i.e. cis,trans/trans,cis) means that either or both of the isomers could be present. § SED between different doses of CLA55 (five per treatment group).
k SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemented CLA55. Table 6 . 
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,0·001 c, cis; t, trans. * Transfer efficiencies of the CLA isomers into porcine tissue were calculated using formulas described on p. 917; for details of diets and procedures, see Tables 1 and 2 and p. 916. † CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). ‡ The slash (/) between geometric isomers (i.e. cis,trans/trans,cis) means that either or both of the isomers could be present. § SED between different doses of CLA55 (five per treatment group).
k SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemented CLA55. † CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). ‡ SED between different doses of CLA55 (five per treatment group). § SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemented CLA55. Table 8 . 0·18 ,0·001
0·007 0·047 0·86 * For details of diets and procedures, see Tables 1 and 2 and p. 916. † CLA nominally contained 55 g CLA isomers/100 g total fatty acids (CLA55; Natural Lipids Ltd, Hovdebygda, Norway). ‡ SED between different doses of CLA55 (five per treatment group). § SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemented CLA55.
CLA. CLA reduced the levels of oleic (18 : 1), arachidic (20 : 0), eicosatrienoic (20 : 3) and arachidonic (20 : 4) acids in a linear fashion, while the content of decosahexaenoic acid (22 : 6) generally tended to be elevated at intermediate levels of dietary CLA. The relative proportions of the lauric (12 : 0), myristic (14 : 0), palmitic (16 : 0) and palmitoleic (16 : 1) acids were increased with the increasing concentration of CLA in the diet, despite their reduced levels in the diets supplemented with CLA ( Table 2 ). The concentrations of linoleic acid (18 : 2) were similar in the inner layer of fat for different levels of dietary CLA supplementation, while they was reduced in a quadratic fashion in the intramuscular fat. The relative proportions of other fatty acids such as capric acid (10 : 0), stearic acid (18 : 0) and g-linolenic acid (18 : 3) were also not affected by dietary CLA (Tables 7 and 8 ).
In the inner layer of fat (Table 7) , CLA supplementation at lower concentrations of dietary CLA of 1·25, 2·50 and 5·00 g/kg diet reduced the level of saturated fatty acids (by 3·90, 6·80 and 2·20 g/100 g total fatty acids respectively) and increased the level of unsaturated fatty acids (by 6·50, 9·30 and 2·30 g/100 g total fatty acids respectively). At dietary CLA levels of 7·50 and 10·00 g/kg the levels of saturated fatty acids were higher (by 1·00 and 2·20 g/100 g total fatty acids) and unsaturated fatty acids were lower (by 1·70 and 3·80 g/100 g total fatty acids) than for the control pigs. However, the difference between the CLA treatments and control pigs were not significant for both the saturated (P¼ 0·28) and unsaturated (P¼ 0·17) fatty acids. The resulting ratio unsaturated : saturated fatty acids increased from 0·50 to 0·53; however, the differences were not significant (P¼ 0·18). There was a trend (P¼ 0·06) towards linear reduction in proportion of monounsaturated (total of 16:1 and 18:1) fatty acids in pigs fed dietary CLA; however, the levels tended to be higher for lower concentrations of dietary CLA (15·94, 16·78, 16·39, 14·22, 14·18 and 13·53 g/100 g total fatty acids for 0·00, 1·25, 2·50, 5·00, 7·50 and 10·00 g/kg CLA respectively).
The increase in the proportion of saturated fats was more evident in the muscle tissue, where there was a significant linear increase (P¼ 0·006; Table 8 ). The highest proportion of saturated fatty acids was found in pigs fed 7·50 g CLA/kg diet: 67·47 compared with 61·14 g/100 g total fatty acids in the control group. In general, CLA-fed pigs had 5·00 g more saturated fatty acids/100 g total fatty acids than control pigs (P¼ 0·07). The proportion of unsaturated fatty acid tended to decrease quadratically (P¼ 0·07), with the lowest level (27·58 g/100 g total fatty acids) detected in pigs fed 7·50 g/kg and the highest in the control group (31·71 g/100 g total fatty acids). This resulted in a quadratic response (P¼ 0·07), of the ratio unsaturated : saturated fatty acids.
In general, CLA-fed pigs had 13·50 % lower ratio unsaturated : saturated fatty acids when compared with the control pigs (P¼ 0·06). The proportion of monounsaturated (16 : 1 and 18 : 1) fatty acids remained unchanged (17·51, 18·04, 16·91, 16·42, 16·43 and 17·09 g/100 g total fatty acids for 0·00, 1·25, 2·50, 5·00, 7·50 and 10·00 g/kg CLA respectively; P¼ 0·44) in CLA-fed pigs.
Discussion
Incorporation of conjugated linoleic acid into tissues
The present results clearly indicate that supplemental dietary CLA was primarily incorporated into adipose tissue and to a lesser extent into intramuscular fat. Low concentrations of CLA, predominantly the most abundant naturally occurring isomer cis,trans-9,11 isomer (Parodi, 1994) , were found in the corresponding tissues of control pigs. The CLA found in tissue from the control pigs probably originated from endogenous desaturation of trans-11-18 : 1 (Gläser et al. 2002) , since there was no CLA detected in the control diet. However, Chin et al. (1994) also reported that the large intestine of rodents had bacteria that had the ability to biohydrogenate linoleic acid to produce cis,trans-9,11 CLA and it is possible that this may occur in the relatively active hindgut of the pig.
The incorporation of individual and total isomers of CLA into adipose tissue increased proportionally with increasing level of dietary CLA, which is in agreement with earlier studies in mice (Belury & Kempa-Steczko, 1997) , rats (Chin et al. 1994; Sugano et al. 1997 ), hamsters (de Deckere et al. 1999 ) and pigs (Kramer et al. 1998) . The difference between the total level of CLA found in the inner and outer layers of subcutaneous fat was very small but consistent across all levels of CLA supplementation, indicating a similar incorporation of CLA isomers into these two fat depots. However, fivefold lower levels of CLA were found in the intramuscular fat (2·88 mg/g fat at the highest level of CLA supplementation) in the present study.
Although the concentration of individual isomers increased with the level of dietary CLA, there was obviously some selectivity in the uptake or incorporation of certain isomers, especially the cis,trans isomers. The calculated transfer efficiencies for the individual isomers showed that the cis,trans-9,11 isomer was most efficiently incorporated (46·40 %) in subcutaneous tissue, whereas in the intramuscular fat, the cis,trans-11,13 isomer was incorporated most efficiently (0·74 %). The preferential enrichment of cis,trans-9,11 is of particular value with respect to potential health benefits, as there is extensive evidence showing anti-cancer properties of this CLA isomer (for reviews, see Whigham et al. (2000) and Pariza et al. (2001) ). The cis,trans-10,12 isomer, which is thought to be responsible for the reduction in lipid accretion and storage in growing animals (de Deckere et al. 1999; Park et al. 1999) , was incorporated less efficiently, in both subcutaneous and intramuscular fat (13·31 and 0·31 % respectively), than the remaining isomers in the trans,cis group (Table 6 ). The isomer selectivity for the transfer efficiencies found in the present study was in agreement with studies in rodents (Park et al. 1999) , dairy cows (Chouinard et al. 1999a,b; Baumgard et al. 2001 ) and pigs (Kramer et al. 1998) . In dairy cows, trans,cis-10,12 is incorporated into milk fat with about one-half the efficiency found for the cis,trans-9,11 isomer (Chouinard et al. 1999a,b) . Kramer et al. (1998) examined the incorporation of commercial CLA in many of the tissue lipid classes of pigs and found that preferential incorporation of the cis,trans-9,11 isomer into liver phospholipids and of the cis,trans-11,13 isomer into heart lipids. In both liver and heart lipids, the relative proportions of trans,cis-10,12 and trans,cis-8,10 were significantly lower than that found in the diet (Kramer et al. 1998) .
These findings imply that the levels of CLA can be increased in pig adipose tissue and intramuscular fat to levels similar to those reported in literature for dairy products (typically 2 -24 mg/g fat). Thus, there is a potential to substantially increase the level of CLA, particularly the cis,trans-9,11 isomer, which is more readily incorporated into animal fats, through supplementing CLA into animal diets and consequently increase CLA intakes in human diets.
Changes in fatty acid composition
Dietary polyunsaturated fats (both n-6 and n-3 fatty acid families) are readily incorporated into porcine adipose tissue lipids in a dose-dependent manner (Fontanillas et al. 1997; Warnants et al. 1999 ) with a resultant decrease in monounsaturated fatty acids, but little effect on saturated fatty acid content (Bee et al. 1999 ). In the present study, diets were formulated to contain CLA and/or soyabean oil. Substitution of soyabean oil with various amounts of CLA resulted in dose-dependent changes in myristic, palimitic, stearic and linolenic acid concentrations in the diets (Table 2) . Hence, some differences in the fatty acid profiles of the tissue lipids were anticipated due to differences in the fatty acid profile in the diets. Therefore, care should be taken in interpreting effects of CLA supplementation on changes in the profiles of other fatty acids.
Despite this caveat, it does appear that some changes in the fatty acid composition of porcine adipose tissue could be attributed to dietary CLA. For example, the concentrations of palmitoleic (16:1) and palmitic (16:0) acids in both intramuscular and subcutaneous fat increased in a linear fashion with increasing dietary CLA. This was clearly due to an effect of dietary CLA, since the level of dietary palmitic acid decreased with increasing dietary CLA. Palmitoleic acid was not detected in the diets; therefore, its origin was from desaturation of the respective saturated fatty acid, palmitic acid, which is in turn regulated by the fatty acyl-CoA D 9 -desaturase complex (Bee, 2000) . The ratio palmitoleic : palmitic acid in the adipose tissue of the CLA supplemented pigs in general was not different from the control group, suggesting little effect of CLA on desaturation activity. When considering the fact that CLA supplementation results in dose-dependant reductions in fat deposition (Ostrowska et al. 1999 (Ostrowska et al. , 2003 , it appears that the increase in the concentration of these fatty acids is more likely to be due to the reduction in the fat deposition in CLA-fed pigs, than altered desaturase activity.
The D 9 -desaturase enzyme complex is also responsible for desaturation of stearic acid into oleic acid. In a present study, the concentration of stearic acid was not affected by dietary CLA despite the levels decreasing as the CLA increased in the diets, but a significant reduction in oleic acid was detected despite similar levels found in all the six diets. Similarly, Bee (2000) and Ramsay et al. (2001) reported a distinct shift toward lower oleic acid concentrations due to dietary CLA. This could be due to the depressed synthesis of oleic acid in the adipose tissue lipids, possibly due to decreasing stearoyl-CoA desaturase activity. Lee et al. (1998) provided evidence that CLA reduces the stearoyl coenzyme A desaturase mRNA abundance in rat liver by 45 %. Similarly, in dairy cows, dietary CLA influenced fatty acid composition of meat and milk through inhibition of desaturases at the level of transcription . In addition, Baumgard et al. (2001) and Peterson et al. (2002) have shown that the inhibition of desaturase is related to dose of CLA and at lower doses (, 7 g/d), where a 30 % reduction in milk fat yield is evident, there is no effect of desaturase activity.
A significant linear reduction in arachidonic acid, in both the adipose tissue and intramuscular fat was detected in CLA-fed pigs. The arachidonic acid was not of dietary origin; therefore, it is likely that it was derived from desaturation of linoleic acid (18 : 2) or/and CLA to g-linolenic acid (18 : 3) by D 6 -desaturase and elongation and subsequent desaturation of dihomo-g-linolenic acid (20 : 3) by a D 5 -desaturase (Stone et al. 1979 ). Therefore, it is possible that CLA inhibits one or two of these specific desaturation steps, which are controlled by D 6 -and D 5desaturases (Innis, 1993) . This was also evident in the synthesis of 22 : 6n-3, which also tended to be sensitive to changes in CLA concentration. The levels of 22 : 6 were above basal levels for pigs fed 1·25, 2·50 and 5·0 g CLA/ kg diet, but were lower at the higher doses of CLA. The content of g-linolenic acid (18 : 3), an intermediate in the elongation and desaturation step of linoleic acid to arachidonic acid, tended to be reduced in the intramuscular fat of CLA-fed pigs, but the response tended to be quadratic in nature. Similarly, in mice and rats, CLA was incorporated into neutral lipids and phospholipids in a dose-response fashion at the expense of linoleate and arachidonate (Belury & Kempa-Steczko, 1997) . While CLA increased, arachidonate decreased significantly while linoleate decreased slightly. The D9,11-18 : 2 isomer of linoleic acid was found to be a precursor for D5,8,11,13-20 : 4 fatty acid (Belury & Kempa-Steczko 1997) . The enzymatic conversion of linoleate or CLA to 18 : 3 products by D 6desaturase was similar, suggesting that the enzyme did not utilize either CLA or linoleate preferentially as a substrate. However, it has not been determined whether CLA competes with linoleate for D 6 -desaturase (Belury & Kempa-Steczko, 1997) .
Overall, myristic, palmitic, palmitoleic and oleic acids were most sensitive to dietary CLA. The relative proportions of saturated fatty acids (16 : 0 and 18 : 0) were significantly increased in the intramuscular fat, but not the adipose tissue and some monounsaturated (18 : 1) and polyunsaturated fatty acids (20 : 3, 20 : 4 and 22 : 6) tended to be reduced by dietary CLA. Overall, saturated fatty acid content tended to be higher in CLA-fed pigs than control pigs and the proportion of unsaturated fatty acid tended to decrease quadratically, with the lowest level detected in pigs fed 7·50 g/kg and the highest in the control group. The resulting increase in the ratio saturated : unsaturated fatty acids is unfavourable, since increased consumption of saturated fatty acids it is also associated with increased risk of CHD. The calculated index of atherogenicity (Ulbricht & Southgate, 1991) , which takes into consideration the CHD protective and promoting properties of fatty acids, was also negatively affected by CLA supplementation. Therefore, applying nutritional techniques to increase the polyunsaturated and monounsaturated fatty acid content of pork to compensate for the effects of CLA should be considered.
Conclusion
In conclusion, based on the analytical data from muscle fat and adipose tissues in the present study, all CLA isomers were incorporated into pig tissue in a dose-dependant manner. However, there appears to be selectivity in the uptake or incorporation of the cis,trans-9,11 isomer over the trans,cis-10,12 isomer. Taking into consideration the differences the biological activities between the isomers of CLA, it is important to assess the optimum levels of the individual isomers in foods and their health benefit. Furthermore, the increases in CLA concentrations in carcass lipids due to CLA supplementation were accompanied by less favourable changes in skeletal muscle and adipose tissue fatty acid composition. Therefore, the benefits of CLA-enriched animal products, possibly in combination with nutritional techniques to increase the polyunsaturated and monounsaturated fatty acid content to compensate for the effects of CLA, need to be evaluated in more detail. Finally, the assessment of the bioavailability and functional properties of newly available esterified CLA preparations containing fewer isomers need to be carried out.
